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study was performed in ISH slides using Leica image Analysis System. Three groups AV 
were analyzed: Group A - 10 autopsy AV from non-atherosclerotic patients. Group B - 10 
autopsy non-stenotic AV of severe atherosclerotic patients. Group C - 10 stenotic AV 
from valvular replacement Results - MP was present in 100% of valves from groups A, B 
and C. MP was diagnosed at electron microscopy as extracellular irregular small struc- 
tures containing granular dots resembling DNA or RNA (confirmed by ISH), a simple 
envelope membrane, with no intracellular organelles. Group B presented higher % area 
of MP than group A (1,8 vs 0,7), that concentrated in the calcified nodules (5,5) seen at 
ISH as small brown dots. Group C had higher amount of ISH positive areas only in the 
calcified areas where the ISH revealed homogeneous taining pattern associated to the 
small dots pattern. The tissue surrounding the calficified areas was usually thickened by 
fibrosis and mononuclear inflammation, and presented significant tess amount of MP 
DNA (0,33) p<0,01. Conclusion - Mycoplasma pneumonias is a frequent bacteria in aor- 
tic valves. A greater amount is present in patients with systemic atherosclerosis, and 
mainly in calcified fool. The fibrotic calcified nodules of SAV present characteristics com- 
patible with old foci of mycoplasma accumulation. The areas of granulation tissue and 
fibrosis surrounding calcified nodules may represent an immune response against bacte- 
ria proliferation. 
1065-144 Cardiovascular Risk Factors and Mortality From the 
Seven Countries Study 40 Years After: The Greek 
Experience 
Chdstos Pitsavos, Chdstine Chrysohoou, John Skoumas, Demosthenes Panaaiotakos. 
Anastasia Katinioti, Anastasios Dontas, Christodoulos Stefanadis, Alessandro Menotti, 
PavIos Toutouzas, University of Athens, Athens, Greece, Epidemio/ogy School, 
University of Minneapolis, Minnesota. 
BACKGROUND. The Seven Countries Study has completed 40-years activity and the 
middle-aged populations tudied at the onset are presently composed of elderly subjects. 
This study aims to examine cardiovascular (CVD) dsk factors in relation to CVD mortality 
in the Corfu cohort and compare these findings with other populations, included in the 
study. 
METHODS. The population studied in this analysis consisted of rural men enrolled at 
f 960 (n=509, 49.7=5.7 years old). Among several factors the conventional CVD dsk fac- 
tors were investigated. Univariate and multivariate survival analyses were performed with 
CVD mortality as the end-point. Cox proportional hazards models were used in order to 
assess the investigated parameters and to compare survival distributions among popula- 
tions. 
RESULTS. The age adjusted 25-year death rate (per 1000) from all causes was 40.4% 
(95% CI 36.2-44.6%), while the 40-years death rate was 86.4% (95% CI 72%-98%). The 
25-years CVD mortality was 7.6% (95% 6.2-9.3%) while the 40-years was 18.2% (95% 
16.9-23.2%). Age (Hazard ratio=t.086, P<0.01), systolic blood pressure (HR=1.023, 
P<0.01), serum cholesterol (HR=1.0043, P<0.01), physical activity (HR=1.051, P<0.01 ), 
body mass index (HR=1.013, P<0.01) and smoking (HR=1.017, P<0.01) were indepen- 
dently associated with 40-year CVD mortality. The observed associations between 
depression (HR=1.007, P<0.07), afternoon siesta (HR=l.01, P<0.08), HDL-cholesterol 
(HR=I.003, P<0.07), subscapular skinfold thickness (HR=1.002, P<0.09) and mortality 
were related on the in- or exclusions of early death (P-value < 0.08). Published data from 
the other cohorts showed lower CVD mortality in the Mediterranean cohorts (Italy, 
Greece and Croatia/ Serbia) compared to the North European and US populations 
(P<0.001). 
CONCLUSION. In these eldedy men age, smoking habits, systolic blood pressure, 
serum cholesterol, body mass and physical activity, were consistently associated with 
CVD mortality. Evidences from other cohorts indicate differences in mortality between 
populations that may attribute to dietary patterns or cultural particularities that they did 
not investigated in the present study. 
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Women's Hospital, Boston, Massachusetts. 
Lycopene remains sparsely tested in prospective studies for its role in the pdmary pre- 
vention of cardiovascular disease (CVD). We therefore determined whether plasma lyco- 
pens levels in middle-aged and older women from the Women's Health Study predicted 
the risk of developing CVD in a prospective, nested case-control design. Baseline bloods 
were collected from 28,263 (71%) of 39,876 women, of whom 483 cases of CVD (includ- 
ing myocardial infarction (MI), stroke, CVD death, revasculadzation procedures, and 
angina) and 483 age- and smoking-matched controls free of CVD dudng an average of 7 
years follow-up were selected. Besides plasma lycopene, other plasma carotanoids and 
total cholesterol (TC) were measured, plus baseline coronary and dietary risk factors. Of 
the 483 cases identified with CVD, there were 109 MIs, 112 strokes, 85 revasculadza- 
tions, 33 CVD deaths, and 144 cases of angina. In analyses matched on age and smok- 
ing, plus adjustment for plasma TC level, the relative risks (RRs) (95% confidence 
intervals) of total CVD for women in the lowest to highest quartiles of plasma lycopene 
were 1.00 (rsf), 0.78 (0.55-1.11), 0.56 (0.39-0.81), and 0.62 (0.43-0.90) (p, linear 
trend=0.004). Upon additional adjustment for coronary risk factors, the RRs of total CVD 
for women in the lowest to highest quartiles of plasma lycopene were 1.00 (ref), 0.94 
(0.60-1.49), 0.62 (0.39-1.00), and 0.67 (0.41-1.11) (p, linear trend=0.05). This pattern in 
RRs suggested a threshold effect in which women in the upper haft of plasma lycopene 
had a significant 34% reduction in the CVD risk. For CVD excluding angina, an L-shaped 
association was apparent as women in the upper three quartiles had a significant multi- 
variate 50% risk reduction compared with those in the lowest quartile of plasma lyco- 
pens. The addition of individual plasma carotenoids did not strongly impact the 
multivariate RRs. In conclusion, we found that higher plasma lycopene levels were asso- 
ciated with a reduced risk of CVD in middle-aged and older women. A better understand- 
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ing of the determinants of plasma lycopene levels is needed to determine how to raise 
plasma lycopene up to a clinically relevant level at which cardiovascular benefits may be 
attained. 
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1086-153 Inter-Relationship of Endothelin-1 and Natrluretic 
PepUde Secretory Responses to Acute Exercise in 
Patient With Chronic Heart Failure and Healthy Controls 
Mohammed Yousufuddin. Waqar Shamim, Marcus Flather, Mohamed Amrani, Andrew J 
S. Coats, National Heart and Lung Institue, London, United Kingdom. 
We investigated the inter-relationship between pathogenic endothelin-1 (ET-t) and 
counter-regulatory atrial (ANP) and brain (BNP) natriuretic peptides in patients with sta- 
ble CHF. Methods: Sixty-men (58+10 yr.) with stable CHF (ischaemic or idiopathic ardi- 
omyopathy only) of NYHA grade I-IV and ejection fraction <40% were enrolled. Sixteen 
age-matched (56_+6) healthy men served as controls. Venous blood samples were 
obtained at rest and peak exercise. Cardiopulmonary exercise was performed using 
modified Bruce treadmill protocol and peak oxygen consumption (VO2) was measured 
(AMIS 2000,Denmark). Investigations were performed after overnight fast. Radioimmu- 
nometric assay (Shionaria, Shionogi,Japan) were used to measure ANP and BNP and 
ELISA (Biotra, Amersham,UK) to measure ET-t. Alternating Conditional Expectation 
Algorithm was used to elucidate the relationship between peptides. Results: Resting 
plasma levels of ANP [median and (interqurtile 25-75%): 12.4 (8.0-2t.4), 4.4 (3.1-5.1) 
pmol/I, P=0.001)], BNP [14.6 (6.0-37.7), 1.15 (0.8-2.3) pmol/1, P<0.0001)], and ET-1 [2.1 
(1.6-2.9), 1.8 (1.2-1.9) pmol/], P=0.05)], were higher in patients than in controls. VO2 was 
higher in controls than in patients (35.8+5.2, 19.9-J:8.1ml/kg/min; P<0.0001). All these 
peptides were significant increased with exercise both in patients and controls (P --0.001 
to <0.0001 ). Resting or peak exercise ET-1 was correlated with resting or peak exercise 
ANP and 8NP (r=0.53 to 0.83; P=g.01to <0.0001) in patients not in controls. Logarithm 
transformed ANP and BNP (resting and peak) were linearly related to resting as well as 
peak ET-1 JR-squared 0.20 - 0.66, Slope 0.89 to 2.41(CI 0.42-1.40 to 1.94-2.88), con- 
stant 0.87 to 2.31 (CI 0.2-1.18 to 1.87-2.75); all P <0.0001). Based on regression models, 
we estimated plasma levels of natriuratic peptidec using resting ET-1 as a predictor. Dou- 
bling in resting ET-1 leads to a predictable increase in ANP (2.18-fold resting and 2.13- 
fold peak exercise) and BNP (5.32-fold resting and 4.45-fold peak exemise). Conclu- 
sions: Rise in plasma ET-I in patients not in controls is associated with predictable 
increase in not only resting but also peak exercise plasma ANP and BNP. 
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Patients Treated With Bats-Blockers Is a Better 
Predictor of Survival Than Peak Oxygen Consumption 
Tatiana O. Tsvetkova. Brian D. Lowes, Alastair D. Robertson, Simon F. Shakar, JoAnn 
Lindenfeld, Michael R. Bristow, Eugene E. Wolfel, University of Colorado Health 
Sciences Center, Denver, Colorado. 
Background: Abnormally high ventilatory response to exercise was shown to be a pow- 
erful and independent predictor of survival in heart failure patients not receiving beta- 
blockers. However, the prognostic value of ventilatory responses in patients chronically 
treated with beta-blockers is unknown. 
Methods: We performed a retrospective review of randomly selected charts available on 
site at University of Colorado Heart Failure Clinic. Adults with chronic heart failure due to 
ischemic and non-ischemic cardiomyopathy, who underwent cardiopulmonary exemise 
testing were included if they were on a beta-blocker in addition to standard medical treat- 
ment of hearl failure. Patients with lung disease were excluded. The abnormally high 
ventilatory response t'o exercise was defined as the value of ventilation to carbon dioxide 
(CO2) production (VENCO2) at peak exercise. Cut off values were based on 80 th percen- 
tile and higher, which corresponds to VENCO2> 44.7, as previously published as a pre- 
dictor of survival in patients not treated with beta-blockers by Robbins M. et al 
(Circulation.1999; t 00:2411-24t 7). The primary end-point was death due to any cause. 
Results: There were 51 patients eligible for analysis. 10 patients had abnormally high 
ventilatory response with mean VENCO 2 = 51.9!--5.7 compared to 41 patients with nor- 
mal ventilatory response 36.5+4.1 (p=0.005). There were no significant difference in age 
59~11 vs. 54_+10 years, LVEF 30%_+13 vs. 30%_+12, etiology 50% vs. 52% of ischemic 
cardiomyopathy, females 20% vs. 22.5 %, peak VO 2 12.1 +~2 vs. 15.6_+4.2 ml/kg/min and 
RER 1.1_+01 vs. 1.1+0.1 between two groups. Kaplan-Meier survival curves at 5 years 
demonstrated a survival rate of 47% in patients with abnormally high ventilatory 
response (VENCO2> 44.7) compared to 98% in those with normal ventilatory response 
(p=0.001). Predicted 5 years survival was 80% for patients with peak VO2 <14 ml/kg/min 
and 86% in patients with peak VO2>14 (p=0.07). 
Conclusions: Abnormally high ventilatory response is a better predictor of survival than 
peak oxygen consumption in heart failure patients treated chronically with beta-blockers. 
